- Home
- DAVEW vs FBIOP Comparison
DAVEW vs FBIOP Comparison
Compare DAVEW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAVEW | FBIOP |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DAVEW | FBIOP |
|---|---|---|
| Price | $1.56 | $16.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.5K | 14.5K |
| Earning Date | 03-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 222.91 | 97.40 |
| EPS | ★ 4.60 | 2.86 |
| Revenue | ★ $554,182,000.00 | $63,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.32 | $5.86 |
| Revenue Growth | ★ 59.67 | 9.69 |
| 52 Week Low | $0.20 | $6.27 |
| 52 Week High | $4.03 | $21.43 |
Technical Indicators
Market Signals| Indicator | DAVEW | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 41.72 |
| Support Level | $1.17 | $16.37 |
| Resistance Level | $1.64 | $18.80 |
| Average True Range (ATR) | 0.19 | 0.52 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 49.09 | 10.84 |
Price Performance
Historical ComparisonAbout DAVEW Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.